EssilorLuxottica adjusts 2024 outlook, shares react to margin focus
25.06.2026 - 14:29:40 | ad-hoc-news.de
By Daniel Hoffmann, Chart & Technicals desk. Reviewed prior to publication on 2026-06-25, 14:29.
EssilorLuxottica S.A. (FR0000033219) is back in focus after its recent guidance update for 2024 and confirmation of margin ambitions, following first-quarter figures that showed continued sales growth. The stock, listed on Euronext Paris and a member of the CAC 40 index, remains under close watch from investors and analysts.
What the latest guidance shows
In its first-quarter 2025 earnings release published on April 24, 2025, EssilorLuxottica reported revenue of around 7.0 billion euros, representing mid-single-digit organic growth versus the prior year, and reiterated its aim for adjusted operating margin expansion over the medium term. The company highlighted steady performance in its Wholesale and Retail segments, with particular strength in North America and emerging markets. EssilorLuxottica investor relations update
The group also confirmed that its 2024 framework remains centered on disciplined cost management, synergies from the Essilor and Luxottica combination, and investments in innovation and brand development. Management pointed to ongoing integration benefits and efficiency programs as drivers for future profitability, while acknowledging currency headwinds that could temper reported growth. These comments reinforced earlier guidance that emphasized sustainable value creation rather than short-term spikes in earnings.
How analysts view the shares
Analyst consensus on EssilorLuxottica has remained constructive, with a majority of research houses rating the stock Buy or Outperform based on its global leadership in eyewear and optical lenses. According to a recent overview by MarketScreener in June 2026, more than 20 analysts follow the company, and the average 12-month price target implies moderate upside from the latest trading levels, reflecting confidence in margin expansion and cash generation. MarketScreener analyst consensus for EssilorLuxottica
This analyst stance contrasts with more cautious views expressed on certain consumer and luxury stocks, where demand volatility and regional risks weigh more heavily on valuations. For EssilorLuxottica, the essential nature of vision correction and the breadth of its portfolio provide a buffer, although analysts still monitor pricing dynamics, competition from smaller lens makers, and macroeconomic factors that could influence discretionary eyewear spending.
More news and data on EssilorLuxottica shares
Track all recent headlines, price data and corporate disclosures on EssilorLuxottica to compare the Paris-listed shares with their peers in global eyewear and consumer stocks.
The product behind the stock
EssilorLuxottica generates its revenue primarily from designing, manufacturing and distributing optical lenses and eyewear frames under brands such as Ray-Ban, Oakley and Vogue Eyewear, as well as from operating global retail chains including LensCrafters and Sunglass Hut. The company also develops advanced lens technologies such as Varilux progressive lenses, leveraging research and development to improve vision correction and comfort for millions of customers worldwide.
Where the stock trades today
EssilorLuxottica shares trade on Euronext Paris under the ticker EL, with recent prices in the mid-180 euro range as of late June 2026, reflecting the company's large-cap status in the European consumer and healthcare-related sector and its inclusion in the CAC 40 index.
EssilorLuxottica at a glance
- Company: EssilorLuxottica S.A.
- ISIN: FR0000033219
- WKN: 851522
- Ticker: EL
- Trading venue: Euronext Paris
- Price (as of 2026-06-25, 12:00): 185.00 EUR
- Market cap: 82,000,000,000 EUR (as of 2026-06-25)
- Sector / industry: Consumer discretionary - Apparel, accessories and eyewear
- Index membership: CAC 40
- Next earnings date: 2026-07-26
This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.
